Asundexian Associated with an Impressive 26% Reduction in Recurrent Stroke Without Increased Bleeding. The OCEANIC-STROKE trial

By

February 6, 2026

First-in-human Trial of CRISPR Gene-editing ANGPTL3 Safely Lowered Cholesterol and Triglycerides

By

November 12, 2025

Tirzepatide Lowers MACE vs Dulaglutide in SURPASS-CVOT Patients With Heart Failure

By

Alberto Castro Molina MD

November 12, 2025

DAPT-MVD: Extended DAPT reduces MACCE in patients with multi-vessel disease after DES

By

Lucas Marinacci MD

November 12, 2025

A Liberal Transfusion Strategy Does Not Significantly Reduce MACE vs a Restrictive Strategy in High Cardiac Risk Patients: The TOP Trial

January 28, 2026

CorCMR: Stress Cardiac MRI Uncovers Hidden Angina and Improves Quality of Life in Patients Without Obstructive Coronary Disease

January 24, 2026

Oral KCl Supplementation Lowers Sodium Load and Blood Pressure in Hypertension: SSTT Trial

January 24, 2026

BETTER-BP: Offering Cash Incentives Improves Anti-Hypertensive Medication Adherence, But Not Blood Pressure Control

January 24, 2026

ABC-AF Trial: Personalized Risk-Based Treatment Did Not Improve Outcomes in Patients with Atrial Fibrillation

January 28, 2026

Interviews

This Week in Medicine: Coronavirus Update with Physicians Throughout the US – Part 4

By

Cardiology Now Media

May 6, 2020

This Week in Medicine: Coronavirus Update with Physicians Throughout the US – Part 3

By

Cardiology Now Media

May 6, 2020

This Week in Medicine: Coronavirus Update with Physicians Throughout the US – Part 2

By

Cardiology Now Media

May 6, 2020